| Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance X Cao, SF Cai, TA Fehniger, J Song, LI Collins, DR Piwnica-Worms, ... Immunity 27 (4), 635-646, 2007 | 1262 | 2007 |
| Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs TA Fehniger, SF Cai, X Cao, AJ Bredemeyer, RM Presti, AR French, ... Immunity 26 (6), 798-811, 2007 | 495 | 2007 |
| Identification of a motif in the carboxyl terminus of β-arrestin2 responsible for activation of JNK3 WE Miller, PH McDonald, SF Cai, ME Field, RJ Davis, RJ Lefkowitz Journal of Biological Chemistry 276 (30), 27770-27777, 2001 | 173 | 2001 |
| Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine SF Cai, RJ Kirby, PN Howles, DY Hui Journal of lipid research 42 (6), 902-909, 2001 | 136 | 2001 |
| Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML M Stahl, K Menghrajani, A Derkach, A Chan, W Xiao, J Glass, AC King, ... Blood advances 5 (5), 1552-1564, 2021 | 119 | 2021 |
| LSD1 inhibition exerts its antileukemic effect by recommissioning PU. 1-and C/EBPα-dependent enhancers in AML M Cusan, SF Cai, HP Mohammad, A Krivtsov, A Chramiec, E Loizou, ... Blood, The Journal of the American Society of Hematology 131 (15), 1730-1742, 2018 | 109 | 2018 |
| Interleukin 12 stimulates ifn-γ–mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance X Cao, K Leonard, LI Collins, SF Cai, JC Mayer, JE Payton, MJ Walter, ... Cancer research 69 (22), 8700-8709, 2009 | 94 | 2009 |
| Genetic and epigenetic determinants of AML pathogenesis SF Cai, RL Levine Seminars in hematology 56 (2), 84-89, 2019 | 93 | 2019 |
| Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia W Xiao, A Chan, MR Waarts, T Mishra, Y Liu, SF Cai, J Yao, Q Gao, ... Blood, The Journal of the American Society of Hematology 137 (10), 1377-1391, 2021 | 58 | 2021 |
| Drugging chromatin in cancer: recent advances and novel approaches SF Cai, CW Chen, SA Armstrong Molecular cell 60 (4), 561-570, 2015 | 57 | 2015 |
| Differential expression of granzyme B and C in murine cytotoxic lymphocytes SF Cai, TA Fehniger, X Cao, JC Mayer, JD Brune, AR French, TJ Ley The Journal of Immunology 182 (10), 6287-6297, 2009 | 49 | 2009 |
| Granzyme B is not required for regulatory T cell–mediated suppression of graft-versus-host disease SF Cai, X Cao, A Hassan, TA Fehniger, TJ Ley Blood, The Journal of the American Society of Hematology 115 (9), 1669-1677, 2010 | 46 | 2010 |
| MEN1 mutations mediate clinical resistance to menin inhibition F Perner, EM Stein, DV Wenge, S Singh, J Kim, A Apazidis, ... Nature 615 (7954), 913-919, 2023 | 42 | 2023 |
| Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition SF Cai, SH Chu, AD Goldberg, S Parvin, RP Koche, JL Glass, EM Stein, ... Cancer discovery 10 (10), 1500-1513, 2020 | 25 | 2020 |
| Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant JP Bewersdorf, A Derkach, L Gowda, K Menghrajani, S DeWolf, JD Ruiz, ... Leukemia & lymphoma 62 (14), 3394-3401, 2021 | 20 | 2021 |
| RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy BJ Ball, M Hsu, SM Devlin, C Famulare, SF Cai, A Dunbar, ... Blood 134, 18, 2019 | 18 | 2019 |
| Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia W Xiao, AD Goldberg, CA Famulare, SM Devlin, NT Nguyen, S Sim, ... haematologica 104 (7), 1378, 2019 | 15 | 2019 |
| A phase Ib/II study of the histone methyltransferase inhibitor pinometostat in combination with azacitidine in patients with 11q23-rearranged acute myeloid leukemia K Menghrajani, SF Cai, SM Devlin, SA Armstrong, R Piekarz, M Rudek, ... Blood 134, 2655, 2019 | 12 | 2019 |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia JGW McCarter, D Nemirovsky, CA Famulare, N Farnoud, AS Mohanty, ... Blood Advances 7 (17), 5000-5013, 2023 | 10 | 2023 |
| BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation B Li, W An, H Wang, T Baslan, S Mowla, A Krishnan, W Xiao, RP Koche, ... Blood, The Journal of the American Society of Hematology 139 (25), 3630-3646, 2022 | 10 | 2022 |
